|
Bootstrapped variable selection in the presence of competing risk
|
|
7
|
96
|
January 12, 2026
|
|
NEJM Trial - proportional hazard assumption
|
|
12
|
332
|
December 1, 2025
|
|
Feedback on BayeScores: A Bayesian AFT Mixture Cure Model for Quantifying Clinical Benefit
|
|
3
|
114
|
November 11, 2025
|
|
Time‐varying covariate vs. “matching on time” to handle second event
|
|
14
|
241
|
October 27, 2025
|
|
Euthanasia as a competing risk
|
|
2
|
121
|
September 17, 2025
|
|
Fine-Gray vs Cause-Specific Cox Regression
|
|
0
|
113
|
September 11, 2025
|
|
Why competing-events are mentioned only in time-to-event framework?
|
|
1
|
147
|
August 24, 2025
|
|
Is Harrell's Concordance Index Not Proper When Using Predicted Times?
|
|
6
|
190
|
July 30, 2025
|
|
Dxy value difference in log-logistic AFT survival model
|
|
2
|
174
|
May 19, 2025
|
|
Forest Plot of HRs in subgroups in Cox model
|
|
12
|
1141
|
May 2, 2025
|
|
Proportional hazard assumption: Schoenfeld Residuals
|
|
1
|
242
|
May 1, 2025
|
|
External validation of a time-to-event prognostic model
|
|
3
|
1330
|
April 25, 2025
|
|
Absolute risk from a Cox-regression model
|
|
7
|
528
|
April 17, 2025
|
|
Survival Modeling with Weibull: Why am I overestimating the effect size in my simulation?
|
|
11
|
851
|
March 14, 2025
|
|
Recombining survival curves when stratifying a time varying categorical variable what is the best practice
|
|
1
|
391
|
March 12, 2025
|
|
Cox.zph after survSplit aregImpute and fit.mult.impute
|
|
1
|
341
|
February 25, 2025
|
|
Differences in Confidence Intervals in Cox Model Predictions
|
|
1
|
419
|
February 25, 2025
|
|
Internal variables with a heavy boundary of zero
|
|
6
|
602
|
February 25, 2025
|
|
How to rank parameters and choose "the best"?
|
|
14
|
1028
|
January 18, 2025
|
|
Summary table of different Cox PHM models to compare them
|
|
7
|
1032
|
December 23, 2024
|
|
How to use parameters of different measurement times?
|
|
3
|
650
|
December 18, 2024
|
|
RMS Cox PH Model
|
|
51
|
6090
|
November 21, 2024
|
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
6
|
8678
|
November 5, 2024
|
|
RMS Case Study in Cox Regression
|
|
4
|
16607
|
September 28, 2024
|
|
Dynamic regression for survival analysis
|
|
0
|
804
|
September 18, 2024
|
|
Andersen-Gill - multistate and time varying covariate
|
|
6
|
1233
|
August 27, 2024
|
|
C-index with clustered data
|
|
1
|
984
|
August 8, 2024
|
|
Marginal Structural Models
|
|
2
|
960
|
July 25, 2024
|
|
Progression in cancer trials
|
|
26
|
5836
|
June 25, 2024
|
|
When should Standardized Mean Differences (SMD) be used? If there is a significant difference, is Cox regression or Propensity Score Matching more appropriate?
|
|
1
|
1452
|
April 17, 2024
|